IQVIA HOLDINGS INC. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
IQVIA HOLDINGS INC. (IQV) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $5.00 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-10-27.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2019-02-19
- IQVIA HOLDINGS INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2017-09-30 was $5.00M.
- IQVIA HOLDINGS INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2017-06-30 was $10.00M.
- IQVIA HOLDINGS INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2015-12-31 was $3.86M.
- IQVIA HOLDINGS INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2016 was $41.00M, a 5.13% increase from fiscal 2015.
- IQVIA HOLDINGS INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2015 was $39.00M, a 95.00% increase from fiscal 2014.
- IQVIA HOLDINGS INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2014 was $20.00M, a 23.43% increase from fiscal 2013.
- IQVIA HOLDINGS INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2013 was $16.20M, a 3384.73% increase from fiscal 2012.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month as first filed |
|---|---|---|---|---|---|
| 2017-09-30 | $5.00M 10-Q · filed 2017-10-27 | $15.00M derived: sum of 2 quarters · filed 2017-10-27 | $18.00M 10-Q · filed 2017-10-27 | ||
| 2017-06-30 | $10.00M 10-Q · filed 2017-08-04 | $13.00M 10-Q · filed 2017-08-04 | |||
| 2016-12-31 | $41.00M 10-K · filed 2019-02-19 | ||||
| 2015-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $39.00M 10-K · filed 2018-02-16 | $39.07M 10-K · filed 2016-02-11 | ||
| 2015-09-30 | $35.14M 10-Q · filed 2015-10-28 | ||||
| 2014-12-31 | $20.00M 10-K · filed 2017-02-16 | $20.30M 10-K · filed 2015-02-12 | |||
| 2013-12-31 | $16.20M 10-K · filed 2016-02-11 | ||||
| 2012-12-31 | $465.00K 10-K · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |